Status:
COMPLETED
Validation of the TOF Cuff Monitor® Which Measures Neuromuscular Block on the Upper Arm
Lead Sponsor:
Christoph Czarnetzki
Conditions:
Neuromuscular Blockade
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Neuromuscular blocking agents (NMBAs) are frequently used in anesthesia and quantitative neuromuscular monitoring is standard care. The TOF WATCH SX® monitor is considered as one of the reference moni...
Detailed Description
Neuromuscular blocking agents (NMBAs) are frequently used in anesthesia for tracheal intubation, artificial ventilation, and continued muscle relaxation during surgical interventions. It is of particu...
Eligibility Criteria
Inclusion
- Patients, age ≥18 to 65 years
- Patient with American Society of Anesthesiology \[ASA\] status I or II
- Patient able to read and understand the information sheet and to sign and date the consent form
- Patient scheduled for elective surgery lasting at least 60 minutes
Exclusion
- Patient with a history of allergy or hypersensitivity to rocuronium
- Patient with pacemaker
- Patients with neuromuscular disease
- Patients with preoperative medications known to influence neuromuscular function (for instance aminoglycosides, phenytoin, lidocaine)
- Patients with electrolyte abnormalities (for instance, hypermagnesemia)
- Patients with a body mass index \<19 or \>30 kg m2
- Patient having participated in any clinical trial within 30 days, inclusive, of signing the informed consent form of the current trial
- Patients undergoing interventions that need a continuous deep NMB (for surgical reasons).
Key Trial Info
Start Date :
June 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 14 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03256955
Start Date
June 23 2017
End Date
May 14 2018
Last Update
October 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Geneva
Geneva, Switzerland, 1205